Back
Kinsale Capital Group, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
19
KNSL
Kinsale Capital Group, Inc.
Last Price:
$398.02
Seasonality Move:
8.01%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.24
Seasonality Move:
-11.9%
Sell
19
Kinsale Capital Group, Inc. (KNSL)
is a Sell
Is Kinsale Capital Group, Inc. a Buy, Sell or Hold?
-
The current Kinsale Capital Group, Inc. [KNSL] share price is $397.45. The Score for KNSL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
KNSL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.25. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSL Stock Price Chart
What is Kinsale Capital Group, Inc.'s stock price today?
-
The Kinsale Capital Group, Inc. share price today is $397.45The current trend is relatively stagnant and KNSL is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
KNSL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.4 | Buy |
| Relative Strength Index (14 RSI): | 52.4 | Buy |
| Chaikin Money Flow: | -112535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (373.72 - 402.32) | Buy |
| Bollinger Bands (100): | (385.12 - 450.26) | Sell |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 65.7 | Buy |
| Chaikin Money Flow: | -2109383 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.45 - 50.61) | Buy |
| Bollinger Bands (100): | (35.52 - 47.68) | Buy |
KNSL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 398.36 | Sell |
| 20-day SMA: | 394.09 | Buy |
| 50-day SMA: | 389.05 | Buy |
| 200-day SMA: | 442.23 | Sell |
| 8-day EMA: | 399.1 | Sell |
| 20-day EMA: | 394.47 | Buy |
| 50-day EMA: | 398.2 | Sell |
| 200-day EMA: | 428.48 | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.43 | Buy |
| 20-day SMA: | 48.84 | Buy |
| 50-day SMA: | 45.85 | Buy |
| 200-day SMA: | 36.19 | Buy |
| 8-day EMA: | 50.48 | Buy |
| 20-day EMA: | 48.82 | Buy |
| 50-day EMA: | 46.16 | Buy |
| 200-day EMA: | 40.41 | Buy |
Kinsale Capital Group, Inc. Earnings Growth & KNSL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $2.25 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
Kinsale Capital Group, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||